Literature DB >> 27892953

Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion.

Sungkun Chun1, Fei Du1, Joby J Westmoreland1, Seung Baek Han1, Yong-Dong Wang2, Donnie Eddins1, Ildar T Bayazitov1, Prakash Devaraju1, Jing Yu1, Marcia M Mellado Lagarde1, Kara Anderson1, Stanislav S Zakharenko1.   

Abstract

Although 22q11.2 deletion syndrome (22q11DS) is associated with early-life behavioral abnormalities, affected individuals are also at high risk for the development of schizophrenia symptoms, including psychosis, later in life. Auditory thalamocortical (TC) projections recently emerged as a neural circuit that is specifically disrupted in mouse models of 22q11DS (hereafter referred to as 22q11DS mice), in which haploinsufficiency of the microRNA (miRNA)-processing-factor-encoding gene Dgcr8 results in the elevation of the dopamine receptor Drd2 in the auditory thalamus, an abnormal sensitivity of thalamocortical projections to antipsychotics, and an abnormal acoustic-startle response. Here we show that these auditory TC phenotypes have a delayed onset in 22q11DS mice and are associated with an age-dependent reduction of miR-338-3p, a miRNA that targets Drd2 and is enriched in the thalamus of both humans and mice. Replenishing depleted miR-338-3p in mature 22q11DS mice rescued the TC abnormalities, and deletion of Mir338 (which encodes miR-338-3p) or reduction of miR-338-3p expression mimicked the TC and behavioral deficits and eliminated the age dependence of these deficits. Therefore, miR-338-3p depletion is necessary and sufficient to disrupt auditory TC signaling in 22q11DS mice, and it may mediate the pathogenic mechanism of 22q11DS-related psychosis and control its late onset.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27892953      PMCID: PMC5218899          DOI: 10.1038/nm.4240

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  67 in total

Review 1.  Search for schizophrenia susceptibility genes.

Authors:  A E Pulver
Journal:  Biol Psychiatry       Date:  2000-02-01       Impact factor: 13.382

Review 2.  Advances in schizophrenia.

Authors:  G K Thaker; W T Carpenter
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

3.  Culture and the prevalence of hallucinations in schizophrenia.

Authors:  Susanne M Bauer; Hans Schanda; Hanna Karakula; Luiza Olajossy-Hilkesberger; Palmira Rudaleviciene; Nino Okribelashvili; Haroon R Chaudhry; Sunday E Idemudia; Sharon Gscheider; Kristina Ritter; Thomas Stompe
Journal:  Compr Psychiatry       Date:  2010-09-06       Impact factor: 3.735

Review 4.  Of dreaming and wakefulness.

Authors:  R R Llinás; D Paré
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

5.  Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives.

Authors:  A E Pulver; G Nestadt; R Goldberg; R J Shprintzen; M Lamacz; P S Wolyniec; B Morrow; M Karayiorgou; S E Antonarakis; D Housman
Journal:  J Nerv Ment Dis       Date:  1994-08       Impact factor: 2.254

Review 6.  A Synaptic Function Approach to Investigating Complex Psychiatric Diseases.

Authors:  Laurie R Earls; Stanislav S Zakharenko
Journal:  Neuroscientist       Date:  2013-08-01       Impact factor: 7.519

Review 7.  Pervasive roles of microRNAs in cardiovascular biology.

Authors:  Eric M Small; Eric N Olson
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

Review 8.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

9.  Recombinant Adeno-Associated Virus-Mediated microRNA Delivery into the Postnatal Mouse Brain Reveals a Role for miR-134 in Dendritogenesis in Vivo.

Authors:  Mette Christensen; Lars A Larsen; Sakari Kauppinen; Gerhard Schratt
Journal:  Front Neural Circuits       Date:  2010-01-12       Impact factor: 3.492

Review 10.  Schizophrenia.

Authors:  Kim T Mueser; Susan R McGurk
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

View more
  23 in total

Review 1.  Neurobiological perspective of 22q11.2 deletion syndrome.

Authors:  Janneke R Zinkstok; Erik Boot; Anne S Bassett; Noboru Hiroi; Nancy J Butcher; Claudia Vingerhoets; Jacob A S Vorstman; Therese A M J van Amelsvoort
Journal:  Lancet Psychiatry       Date:  2019-08-05       Impact factor: 27.083

2.  Psychiatric disorders: Age-dependent auditory abnormalities.

Authors:  Natasha Bray
Journal:  Nat Rev Neurosci       Date:  2016-12-15       Impact factor: 34.870

Review 3.  Critical reappraisal of mechanistic links of copy number variants to dimensional constructs of neuropsychiatric disorders in mouse models.

Authors:  Noboru Hiroi
Journal:  Psychiatry Clin Neurosci       Date:  2018-03-01       Impact factor: 5.188

4.  MicroRNA-338 modulates cortical neuronal placement and polarity.

Authors:  Aron Kos; Annetrude J de Mooij-Malsen; Hans van Bokhoven; Barry B Kaplan; Gerard J Martens; Sharon M Kolk; Armaz Aschrafi
Journal:  RNA Biol       Date:  2017-05-11       Impact factor: 4.652

5.  Dissociable Disruptions in Thalamic and Hippocampal Resting-State Functional Connectivity in Youth with 22q11.2 Deletions.

Authors:  Charles Schleifer; Amy Lin; Leila Kushan; Jie Lisa Ji; Genevieve Yang; Carrie E Bearden; Alan Anticevic
Journal:  J Neurosci       Date:  2018-11-26       Impact factor: 6.167

6.  Differential resting-state patterns across networks are spatially associated with Comt and Trmt2a gene expression patterns in a mouse model of 22q11.2 deletion.

Authors:  Natalia Gass; Zeru Peterson; Jonathan Reinwald; Alexander Sartorius; Wolfgang Weber-Fahr; Markus Sack; Junfang Chen; Han Cao; Michael Didriksen; Tine Bryan Stensbøl; Gabrielle Klemme; Adam J Schwarz; Emanuel Schwarz; Andreas Meyer-Lindenberg; Thomas Nickl-Jockschat
Journal:  Neuroimage       Date:  2021-08-26       Impact factor: 7.400

Review 7.  A genetics-first approach to understanding autism and schizophrenia spectrum disorders: the 22q11.2 deletion syndrome.

Authors:  Ania M Fiksinski; Gil D Hoftman; Jacob A S Vorstman; Carrie E Bearden
Journal:  Mol Psychiatry       Date:  2022-10-03       Impact factor: 13.437

Review 8.  To the end of the line: Axonal mRNA transport and local translation in health and neurodegenerative disease.

Authors:  Christopher J Costa; Dianna E Willis
Journal:  Dev Neurobiol       Date:  2017-11-13       Impact factor: 3.964

9.  Heterozygosity of murine Crkl does not recapitulate behavioral dimensions of human 22q11.2 hemizygosity.

Authors:  Takahira Yamauchi; Gina Kang; Noboru Hiroi
Journal:  Genes Brain Behav       Date:  2020-12-10       Impact factor: 3.449

10.  Aberrant Temporal Connectivity in Persons at Clinical High Risk for Psychosis.

Authors:  Tiziano Colibazzi; Zhen Yang; Guillermo Horga; Yan Chao-Gan; Cheryl M Corcoran; Kristin Klahr; Gary Brucato; Ragy Girgis; Anissa Abi-Dargham; Michael P Milham; Bradley S Peterson
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.